Guardian Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Guardian Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $1,159 - $1,321	15 New	15 $1,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $139,144 - $158,939	2,337 New	2,337 $144,000
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $331,313 - $362,006	-5,220 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $313,200 - $357,361	5,220 New	5,220 $337,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.